Jama Pitman - 17 Jan 2023 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc.

Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
17 Jan 2023
Net transactions value
-$34,050
Form type
4
Filing time
19 Jan 2023, 15:06:00 UTC
Previous filing
21 Jun 2022
Next filing
17 Feb 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCPH Common Stock Sale $34,050 -1,603 -4.4% $21.24 35,058 17 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was to cover tax liabilities in the vesting of restricted stock.

Remarks:

Title: SVP, Regulatory, Quality, & Portfolio Management